Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis (CHP-HRQOL)
Sponsor: Pulmonary Fibrosis Foundation
A observational or N/A phase clinical study on Chronic Hypersensitivity Pneumonitis and Extrinsic Allergic Alveolitis, this trial is completed. The trial is conducted by Pulmonary Fibrosis Foundation and has accumulated 12 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Aug 2023 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2022 — Aug 2023 [monthly]
Recruiting
-
Feb 2022 — Sep 2022 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Oct 2021 — Feb 2022 [monthly]
Recruiting
-
Apr 2021 — Oct 2021 [monthly]
Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
-
Aug 2020 — Jan 2021 [monthly]
Recruiting
Status: Suspended → Recruiting
-
May 2020 — Aug 2020 [monthly]
Suspended
Status: Recruiting → Suspended
-
Apr 2020 — May 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Pulmonary Fibrosis Foundation
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .